ea0015p56 | Clinical practice/governance and case reports | SFEBES2008
Olateju Tolu
, Jaleel Nihad
, Kar Partha
, Atkin Marc
, Meeking Darryl
Prolonged use of oral corticosteroid treatment is associated with cushingoid side effects and HPA suppression. We are increasingly seeing similar problems associated with nasal steroid therapy.Case 1: A 41-year-old lady with history of asthma, allergic rhinitis and nasal polyps presented with a clinical appearance of Cushings syndrome. Her medication included Becloforte inhalers 250 mg tds and Betamethasone sodium phosphate nasal drops 0.1% 2 drops bd, b...